Lifeboat Foundation

Doctors are reaching for drugs that dampen the immune response — but these also undermine the body’s own fight against the coronavirus. Uncertainty is hampering doctors’ ability to choose treatments.

At the height of the epidemic in the city, Jinyintan was treating close to 500 coronavirus patients, he said. It currently still has 123 under observation, he said. A study published last month in the New England Journal of Medicine, based on a test in Chinese patients with severe COVID-19 at Jinyintan, said that Kaletra, also known as Aluvia, was not effective as a potential treatment.

Last month, Israel approved the licensing of a generic version of Kaletra to treat patients infected with the coronavirus.

A lunar crater on the farside of the Moon could be turned into a new radio telescope resembling the Death Star from Star Wars, under new plans from NASA.

Funding for the project has come from the NASA Innovative Advanced Concepts (NIAC) Programme, designed to support potentially game changing projects.

Continue reading “NASA reveals plans for a radio telescope on the farside of the Moon” »

Sarkis Tatigian joined the Navy in 1942. He’s been there ever since, until his death this week at the age of 96.

Tatigian — who first enlisted as a radio inspector at the now-defunct Philadelphia Naval Shipyard — went on to become the small business advocate at Naval Sea Systems Command. He had held that title since 1979, six years after he first became eligible for retirement. But he’d been working on the Navy’s small business programs since 1951, two years before the Small Business Administration even existed.

Even well into his 90s, Tatigian reportedly commuted to work at the Washington Navy Yard via public transit every day. When we last spoke to him in late 2017, he had only taken one vacation day that year.

A conspiracy theory linking 5G wireless networks to the Covid-19 pandemic is spreading. The theory is false — and psychologists explain why it is still so popular.

Many companies have made strong commitments to support their employees, customers, suppliers and communities through what is perhaps the gravest global crisis since the second world war. And all at a time when they are themselves counting the costs of lockdowns and physical distancing.

Others have joined more directly in fighting the outbreak. Amazon is distributing coronavirus tests, Diageo is making hand sanitiser, while Formula 1 teams are designing ventilators.

But business has a powerful opportunity to go further and play a critical part in resolving the crisis — as well as in managing it — by helping fund the vital research that provides the only viable exit strategy that can bring the world back to business as usual.

A brain–machine interface that enables multi-channel recordings of neural activity could improve human prosthetics and enhance understanding of the brain.

It also said it plans to support studies to determine whether existing Pfizer medicines, including its rheumatoid arthritis drug Xeljanz, may provide benefits for those struggling with the COVID-19 respiratory illness caused by the coronavirus. More than a dozen large drugmakers, including Pfizer, have announced plans in recent months to develop vaccines and treatments for the coronavirus, although few if any are likely to reach patients in time to stem the current outbreak. Pfizer first revealed plans to try to develop an antiviral compound for COVID-19 in March, and later said it was working with BioNTech SE (22UAy. F) on a potential vaccine based on messenger RNA technology.

U.S. drugmaker Pfizer Inc said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients infected with the novel coronavirus.

A total solar eclipse is coming to the US, Canada and Mexico.